학술논문
P30 Potential Impacts of the New MHRA Policy for Biosimilar Approval for the Industry and Patients
Document Type
Abstract
Author
Source
In Value in Health January 2022 25(1) Supplement:S7-S7
Subject
Language
ISSN
1098-3015